ARAY - Accuray Incorporated
NEXT EARNINGS:
Apr 29, 2026
EPS Est: $-0.05
|
Rev Est: $111.9M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$2.00
DETAILS
HIGH:
$2.00
LOW:
$2.00
MEDIAN:
$2.00
CONSENSUS:
$2.00
UPSIDE:
237.21%
Market Cap:
70.45M
Volume:
1,404,919
Avg Volume:
1,005,130
52 Week Range:
0.5-2.13
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.15
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
987
IPO Date:
2007-02-08
EPS (TTM):
-0.02
P/E Ratio:
-88.49
Revenue (TTM):
458.50M
Total Assets:
470.24M
Total Debt:
176.38M
Cash & Equiv:
57.42M
Rev Growth (5Y):
3.7%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
5.1%
Debt/Equity:
2.17
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $-0.11 | $-0.02 | -450.0% | $102.2M | $121.2M | -15.6% |
| 2025-11-05 | $-0.18 | $-0.01 | -1700.0% | $93.9M | $122.9M | -23.6% |
| 2025-08-13 | $0.01 | $0.03 | -65.6% | $127.5M | $93.0M | +37.2% |
| 2025-04-30 | $-0.01 | $-0.05 | +80.0% | $113.2M | $123.8M | -8.5% |
| 2025-02-05 | $0.02 | $-0.01 | +300.0% | $116.2M | $110.4M | +5.3% |
| 2024-11-06 | $-0.04 | $-0.03 | -24.5% | $101.5M | $97.5M | +4.1% |
| 2024-09-19 | $0.03 | — | — | $134.3M | — | — |
| 2024-05-01 | $-0.06 | $-0.01 | -380.0% | $101.1M | $121.5M | -16.8% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 458.50M | 446.55M | 447.61M | 429.91M | 396.29M | 382.93M | 418.79M | 404.90M | 383.41M | 398.80M | 379.80M | 369.42M |
| Net Income | (1.59M) | (15.54M) | (9.28M) | (5.35M) | (6.31M) | 3.83M | (16.43M) | (23.90M) | (29.58M) | (25.50M) | (40.21M) | (35.45M) |
| EPS | -0.02 | -0.16 | -0.10 | -0.06 | -0.07 | 0.04 | -0.19 | -0.28 | -0.36 | -0.32 | -0.51 | -0.47 |
| Total Assets | 470.24M | 468.63M | 479.21M | 472.85M | 480.10M | 490.93M | 438.18M | 378.73M | 406.46M | 469.03M | 469.97M | 495.19M |
| Total Debt | 176.38M | 210.75M | 205.04M | 199.49M | 199.41M | 221.70M | 159.84M | 131.08M | 164.57M | 210.41M | 202.85M | 195.61M |
| Cash & Equivalents | 57.42M | 68.57M | 89.40M | 88.74M | 116.37M | 107.58M | 76.80M | 83.08M | 72.08M | 119.77M | 79.55M | 92.35M |
| Operating Cash Flow | 2.86M | (11.90M) | 15.54M | (2.40M) | 38.51M | (1.47M) | (29.64M) | 18.33M | (380,000) | 33.54M | (16.73M) | 346,000 |
| Free Cash Flow | (5.66M) | (15.51M) | 2.86M | (7.12M) | 36.19M | (5.20M) | (33.95M) | 11.72M | (5.74M) | 25.47M | (27.18M) | (11.59M) |
| FCF per Share | -0.06 | -0.16 | 0.03 | -0.08 | 0.39 | -0.06 | -0.39 | 0.14 | -0.07 | 0.32 | -0.35 | -0.15 |
| Book Value | 81.17M | 45.08M | 53.66M | 53.19M | 68.84M | 63.63M | 49.87M | 48.63M | 46.53M | 59.66M | 75.78M | 98.55M |
| Cash & ST Investments | 57.42M | 68.57M | 89.40M | 88.74M | 116.37M | 107.58M | 76.80M | 83.08M | 95.99M | 167.01M | 143.86M | 171.90M |
| ROC Equity | -0.02 | -0.34 | -0.17 | -0.10 | -0.09 | 0.06 | -0.33 | -0.49 | -0.64 | -0.43 | -0.53 | -0.36 |